DE3690206T1 - - Google Patents

Info

Publication number
DE3690206T1
DE3690206T1 DE19863690206 DE3690206T DE3690206T1 DE 3690206 T1 DE3690206 T1 DE 3690206T1 DE 19863690206 DE19863690206 DE 19863690206 DE 3690206 T DE3690206 T DE 3690206T DE 3690206 T1 DE3690206 T1 DE 3690206T1
Authority
DE
Germany
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19863690206
Other languages
German (de)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DE3690206T1 publication Critical patent/DE3690206T1/de
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19863690206 1985-05-03 1986-04-30 Ceased DE3690206T1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73076185A 1985-05-03 1985-05-03
US78876285A 1985-10-18 1985-10-18

Publications (1)

Publication Number Publication Date
DE3690206T1 true DE3690206T1 (bg) 1987-09-17

Family

ID=27112105

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19863690206 Ceased DE3690206T1 (bg) 1985-05-03 1986-04-30

Country Status (3)

Country Link
DE (1) DE3690206T1 (bg)
GB (1) GB2185254B (bg)
WO (1) WO1986006628A1 (bg)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177075A (en) * 1988-08-19 1993-01-05 Warner-Lambert Company Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
US5589483A (en) * 1994-12-21 1996-12-31 Geron Corporation Isoquinoline poly (ADP-ribose) polymerase inhibitors to treat skin diseases associated with cellular senescence
AU1743997A (en) * 1996-12-20 1998-07-17 Geron Corporation Poly(adp-ribose) polymerase inhibitors to treat diseases associated with cellular senescence

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1230018A (bg) * 1967-06-06 1971-04-28
DE2106509A1 (de) * 1970-02-13 1971-08-19 Recherches Pharmaceutiques et Seien tifiques, Paris, Omnium Chimique S A , Brüssel Aryloxy propanolamine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL45396A0 (en) * 1973-08-23 1974-11-29 Beecham Group Ltd Pharmaceutical compositions containing aryl aralkyl ether and thioether derivatives,certain such novel compounds and their preparation
AU522049B2 (en) * 1978-01-13 1982-05-13 Van Scott, Eugene Joseph Treatment of psoriasis
CA1110628A (en) * 1978-08-25 1981-10-13 Tosaku Miki N-phenethylacetamide compounds and process for preparation thereof
JPS5874680A (ja) * 1981-10-01 1983-05-06 Kyowa Hakko Kogyo Co Ltd β−ラクタム化合物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1230018A (bg) * 1967-06-06 1971-04-28
DE2106509A1 (de) * 1970-02-13 1971-08-19 Recherches Pharmaceutiques et Seien tifiques, Paris, Omnium Chimique S A , Brüssel Aryloxy propanolamine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Chem. Abstr. 93:61755s (1980), Junji Miyakoshi et.al., Radiation Research 102, S. 359-366 (1985) *
John T. Edward et.al., Canadian J. Chem. 55 (1977), S. 2331-2335 *
Yasuhiro Morisawa et.al., Journal of Medicinal Chemistry, Vol. 20, Nr. 1 (1977), S. 129-133 *

Also Published As

Publication number Publication date
GB8630514D0 (en) 1987-01-28
GB2185254A (en) 1987-07-15
GB2185254B (en) 1989-09-13
WO1986006628A1 (en) 1986-11-20

Similar Documents

Publication Publication Date Title
GR3003951T3 (bg)
DE3680864D1 (bg)
IN161912B (bg)
FR2580004B1 (bg)
DE3690206T1 (bg)
DE3590720T1 (bg)
GR851840B (bg)
GR850694B (bg)
GR852264B (bg)
GR851885B (bg)
GR852565B (bg)
GR851737B (bg)
GR852580B (bg)
GR852503B (bg)
GR850648B (bg)
GR850630B (bg)
GR850218B (bg)
GR850119B (bg)
GR853014B (bg)
GR850896B (bg)
GR851721B (bg)
BG45486A1 (bg)
BG45195A1 (bg)
BG45495A1 (bg)
IL76509A0 (bg)

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8131 Rejection